FDA-cleared profile

3mensio Workstation

Pie Medical Imaging BV · Radiological images; modality varies or is not specified in FDA list · FDA-cleared (510(k))

3mensio Workstation is standalone medical-image analysis software for advanced visualization and quantitative analysis of cardiovascular structures. It supports CT, X-ray angiography, and two- and three-dimensional ultrasound DICOM data for planning and sizing cardiovascular interventions, postoperative evaluation, coronary measurements, and calcium scoring.

Clinical role
Image post-processing software that views CT/X-Ray angiographic and ultrasound images, segments cardiovascular structures, and analyzes and quantifies them for diagnostics in cardiology and radiology, including pre-operational planning and sizing for cardiovascular interventions and surgery.
Images and patients
Radiological images; modality varies or is not specified in FDA list · Heart/Cardiovascular
Key limitation
Not publicly available

Overview status: Field-derived fact summary This section is assembled from the sourced field records below; it is not a source-reviewed editorial overview.

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • Imaging and anatomyRadiological images; modality varies or is not specified in FDA list · Heart/Cardiovascular
  • Workflow roleImage post-processing software that views CT/X-Ray angiographic and ultrasound images, segments cardiovascular structures, and analyzes and quantifies them for diagnostics in cardiology and radiology, including pre-operational planning and sizing for cardiovascular interventions and surgery.
  • Required inputVendor-independent CT, X-ray angiography, and two- or three-dimensional ultrasound data in DICOM format.
  • Output and human actionAdvanced visualization, segmentation, cardiovascular measurements, calcium quantification, annotations, and reports for qualified-user review.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
3mensio Workstation is standalone medical-image analysis software for advanced visualization and quantitative analysis of cardiovascular structures. It supports CT, X-ray angiography, and two- and three-dimensional ultrasound DICOM data for planning and sizing cardiovascular interventions, postoperative evaluation, coronary measurements, and calcium scoring.
  • Exact FDA submission
  • Checked 2026-08-31
Workflow role
Image post-processing software that views CT/X-Ray angiographic and ultrasound images, segments cardiovascular structures, and analyzes and quantifies them for diagnostics in cardiology and radiology, including pre-operational planning and sizing for cardiovascular interventions and surgery.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "3mensio Workstation is an image post-processing software package for advanced visualization and analysis for diagnostics in the field of cardiology and radiology" … "offers functionality to view CT/X-Ray angiographic and ultrasound images, to segment cardiovascular structures in these images and to analyze and quantify these cardiovascular structures". Read from the exact FDA decision document on 2026-11-14.

Required input
Vendor-independent CT, X-ray angiography, and two- or three-dimensional ultrasound data in DICOM format.
  • Exact FDA submission
  • Checked 2026-08-31
Output and clinician action
Advanced visualization, segmentation, cardiovascular measurements, calcium quantification, annotations, and reports for qualified-user review.
  • Exact FDA submission
  • Checked 2026-08-31
Intended users
Cardiologists, radiologists, and clinical specialists using the software for cardiovascular image review, measurement, and procedural planning.
  • Exact FDA submission
  • Checked 2026-08-31
Evidence summary
The FDA 510(k) summary reports non-clinical verification and validation but no independent clinical performance study or comparative clinical endpoint.
  • Exact FDA submission
  • Checked 2026-08-31

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The FDA 510(k) summary reports non-clinical verification and validation but no independent clinical performance study or comparative clinical endpoint.
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Reported sensitivity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
FDA Class II recall Z-2767-2026 covers 3mensio Workstation versions 10.7 through 10.7 SP5 under specified Philips 3D echocardiography Color Doppler conditions. The FDA record states the issue was resolved in version 10.7 SP6; the recall remains open and classified in the reviewed record.
  • FDA source
  • Exact product version
  • Checked 2026-09-02

recall: Z-2767-2026

FDA Class II; open, classified

2026-07-21

The firm initiated the correction on 2026-05-07. Under the specific affected configuration, measurements could be reported 0.8% to 34.4% larger than the actual anatomical dimension. FDA lists versions 10.7 through 10.7 SP5 as affected and states the issue was resolved in 10.7 SP6. Confirm installed versions and completion of the correction locally.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Vendor-independent CT, X-ray angiography, and two- or three-dimensional ultrasound data in DICOM format.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-08-31 · K250330 FDA 510(k) decision summary

  2. Routing

    Source context, not route validation: Imports DICOM from accessible file systems, local storage, CT systems, or PACS; results and images with overlays can be exported to network storage or PACS.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-08-31 · K250330 FDA 510(k) decision summary

  3. AI processing

    Source context, not route validation: Available as a standalone Windows package or a web-based solution for network, on-premises, or cloud environments.

    Scope: Exact FDA submission.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-08-31 · K250330 FDA 510(k) decision summary

  4. Returned objects

    Source context, not route validation: Advanced visualization, segmentation, cardiovascular measurements, calcium quantification, annotations, and reports for qualified-user review.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-08-31 · K250330 FDA 510(k) decision summary

  5. Viewer/worklist/report

    Unresolved route: Advanced visualization, segmentation, cardiovascular measurements, calcium quantification, annotations, and reports for qualified-user review.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-08-31 · K250330 FDA 510(k) decision summary

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
Available as a standalone Windows package or a web-based solution for network, on-premises, or cloud environments.
  • Exact FDA submission
  • Checked 2026-08-31
Integration
Imports DICOM from accessible file systems, local storage, CT systems, or PACS; results and images with overlays can be exported to network storage or PACS.
  • Exact FDA submission
  • Checked 2026-08-31

Supported input data

Vendor-independent CT, X-ray, and two- or three-dimensional ultrasound data in DICOM format.

exact submission · checked 2026-08-31

Confirm current scanner, protocol, DICOM object, and software-version compatibility during local technical validation.

PACS and result routing

The FDA summary describes import from CT or PACS and export of results and clinical images with overlays to network storage or PACS.

exact submission · checked 2026-08-31

Confirm current interface versions, routing behavior, and viewer requirements with the vendor.

Deployment model

Standalone Windows and web-based deployments are described, including on-premises and cloud environments.

exact submission · checked 2026-08-31

Hosting region, PHI flow, tenancy, retention, and current commercial packaging require vendor confirmation.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K250330
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Radiological images; modality varies or is not specified in FDA list
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Anatomy
Heart/Cardiovascular
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2025-11-03
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-04Last searched
18Fields reviewed
6Source classes checked
0Awaiting review PubMed leads
0Awaiting review trial leads
0Unreviewed FDA recall leads

Recovered from the prior exact-submission extraction and normalized under the current provenance rules. The exact FDA decision summary and exact-submission recall record were manually reviewed. Commercial security, training, monitoring, pricing, and reimbursement remain separate verification tasks. Automated exact-name discovery found 0 PubMed and 0 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 1 postmarket candidate record; 1 has been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads remain unpublished until a human confirms the exact product and tested version.

Source classes: fda ai list, fda decision summary, fda device recall, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Care setting: Not publicly available - checked 2026-11-14 - Exact FDA submission

    The exact FDA decision document was reviewed on 2026-11-14 and does not state a care setting or patient population for the subject device. Confirm intended sites and patients with the vendor and local policy.

  • Limitations: Not publicly available - checked 2026-11-14 - Exact FDA submission

    The exact FDA decision document was reviewed on 2026-11-14 and states no use limitation for the subject device beyond its indication. Confirm contraindications and labeled limits in the current labeling.

  • Public pricing: Not verified - checked 2026-10-27 - Exact FDA submission

    No public price or quote for the exact K250330 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "Pie Medical Imaging CAAS reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. No result was a vendor or payer page naming this product with coding or payment; any results were general billing guidance. This records what was found, not that none exists.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded search 2026-10-26: Pie Medical Imaging's only owning-domain policy page is a GDPR personal-data privacy notice (website/customer data scope, not product security); no product security statement located. Pie Medical Imaging states it is a fully owned Esaote Group subsidiary (recorded as a lead for a future Esaote-level bridge).

  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-10-27 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-10-27 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

6 sources - 2 history items

Source ledger

  1. K250330 FDA 510(k) decision summary

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: purpose, modality, anatomy, intendedUsers, input, output, integration, deployment, evidenceSummary

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. FDA Class II recall Z-2767-2026 for 3mensio Workstation

    U.S. Food and Drug Administration - Published 2026-07-21 - Accessed 2026-09-02

    Scope: postmarketSafety, affectedVersions, recallStatus, correctiveAction

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

Research history

  1. K250330 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

Alternatives

Related tools to compare

FDA-cleared K191125

ADAS 3D

Galgo Medical S.L

Authorized purpose: ADAS 3D post-processes contrast cardiac MRI and CTA to visualize and quantify myocardial scar and export reviewed results to electrophysiology navigation systems; it is not intended to identify ablation targets.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Heart/Cardiovascular
Decision
2020-01-15
FDA-cleared K141480

CVI42

CIRCLE CARDIOVASCULAR IMAGING INC

Authorized purpose: cvi42 analyzes cardiovascular CT and MRI with MPR, MIP, volume rendering, centerlines, lumen and stenosis measurements, and reporting for qualified professionals.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Heart/Cardiovascular
Decision
2014-08-22
FDA-cleared K253969

ADAS 3D

Adas3D Medical S.L.

Authorized purpose: ADAS 3D supports visualization and analysis of MR and CT images of the heart for individual patients with cardiovascular disease, including patients with myocardial scar from ischemic or non-ischemic heart disease. Qualified professionals may use it for cardiac calculation, quantification, visualization, pre-planning, and electrophysiology procedures; produced data support clinical decision-making and must not be used as irrefutable medical advice or for radiotherapy planning, dose calculation, or treatment delivery.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Heart; myocardial scar and cardiac structures
Decision
2026-06-29

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history